What did the Cambridge researchers discover about the NANOG gene's role in human embryonic development using base editing?

The Cambridge researchers, led by Kathy Niakan, used base editing to deactivate the NANOG gene in human embryos and demonstrated that NANOG is required for proper cell differentiation at this early stage of development — a finding published in Nature (2026, DOI: 10.1038/s41586-026-10792-1). This study is the first to apply base editing in human embryos specifically to investigate human embryonic development, revealing NANOG as a 'master gene' essential for the emergence and specialization of the very first cell types in the human embryo.

How does the Cambridge study differ in purpose from the recent Columbia University base-editing study in human embryos?

While the Columbia University study, led by Dieter Egli, used base editing to correct disease-causing mutations in human embryos — aiming toward potential clinical application in IVF — the Cambridge study used base editing solely to investigate fundamental biology, specifically the role of the NANOG gene in early human embryonic development. As stated in the news, the Cambridge work is 'the first demonstration of base editing in human embryos for the purpose of understanding human embryonic development', distinguishing it clearly from Columbia’s therapeutic-correction focus.

Cambridge Researchers Use Base Editing to Study Essential Gene in Human Embryos

Jun 25, 2026

Researchers at the University of Cambridge utilized base editing on human embryos to identify the critical role of the NANOG gene in early development. This study represents the first demonstration of such editing for developmental research, though safety concerns remain regarding its clinical application.

cen

2026-06-08

Editorial: Skepticism—and success—matters on AI and vaccines

2026-06-25

Cambridge Researchers Use Base Editing to Study Essential Gene in Human Embryos

Cambridge Researchers Use Base Editing to Study Essential Gene in Human Embryos

FAQ